Cargando…
Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168485/ https://www.ncbi.nlm.nih.gov/pubmed/33147939 http://dx.doi.org/10.3324/haematol.2020.263228 |
| _version_ | 1783701886524719104 |
|---|---|
| author | Mozas, Pablo Piñeyroa, Juan A. Nadeu, Ferran Magnano, Laura Rivero, Andrea Rivas-Delgado, Alfredo Bataller, Alex Fabregat, Aleix Giné, Eva Baumann, Tycho Villamor, Neus Aróstegui, Juan Ignacio Aymerich, Marta López-Guillermo, Armando Campo, Elías Delgado, Julio |
| author_facet | Mozas, Pablo Piñeyroa, Juan A. Nadeu, Ferran Magnano, Laura Rivero, Andrea Rivas-Delgado, Alfredo Bataller, Alex Fabregat, Aleix Giné, Eva Baumann, Tycho Villamor, Neus Aróstegui, Juan Ignacio Aymerich, Marta López-Guillermo, Armando Campo, Elías Delgado, Julio |
| author_sort | Mozas, Pablo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8168485 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81684852021-06-11 Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact Mozas, Pablo Piñeyroa, Juan A. Nadeu, Ferran Magnano, Laura Rivero, Andrea Rivas-Delgado, Alfredo Bataller, Alex Fabregat, Aleix Giné, Eva Baumann, Tycho Villamor, Neus Aróstegui, Juan Ignacio Aymerich, Marta López-Guillermo, Armando Campo, Elías Delgado, Julio Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-11-05 /pmc/articles/PMC8168485/ /pubmed/33147939 http://dx.doi.org/10.3324/haematol.2020.263228 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Mozas, Pablo Piñeyroa, Juan A. Nadeu, Ferran Magnano, Laura Rivero, Andrea Rivas-Delgado, Alfredo Bataller, Alex Fabregat, Aleix Giné, Eva Baumann, Tycho Villamor, Neus Aróstegui, Juan Ignacio Aymerich, Marta López-Guillermo, Armando Campo, Elías Delgado, Julio Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact |
| title | Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact |
| title_full | Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact |
| title_fullStr | Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact |
| title_full_unstemmed | Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact |
| title_short | Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact |
| title_sort | serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168485/ https://www.ncbi.nlm.nih.gov/pubmed/33147939 http://dx.doi.org/10.3324/haematol.2020.263228 |
| work_keys_str_mv | AT mozaspablo serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT pineyroajuana serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT nadeuferran serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT magnanolaura serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT riveroandrea serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT rivasdelgadoalfredo serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT batalleralex serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT fabregataleix serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT gineeva serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT baumanntycho serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT villamorneus serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT arosteguijuanignacio serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT aymerichmarta serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT lopezguillermoarmando serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT campoelias serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact AT delgadojulio serummonoclonalcomponentinchroniclymphocyticleukemiabaselinecorrelationsandprognosticimpact |